Benitec Biopharma Inc.BNTCNASDAQ
Loading
Year-over-year operating income growth rate
Latest
-36.46%
↓ 893% vs avg
Percentile
P15
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-3.67%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -36.46% |
| Q3 2025 | 42.93% |
| Q2 2025 | -68.59% |
| Q1 2025 | -18.33% |
| Q4 2024 | -48.68% |
| Q3 2024 | -4.38% |
| Q2 2024 | -33.88% |
| Q1 2024 | 40.18% |
| Q4 2023 | -17.93% |
| Q3 2023 | -29.10% |
| Q2 2023 | -4.81% |
| Q1 2023 | 22.62% |
| Q4 2022 | -22.49% |
| Q3 2022 | 3.33% |
| Q2 2022 | -36.94% |
| Q1 2022 | 28.44% |
| Q4 2021 | -0.27% |
| Q3 2021 | -25.08% |
| Q2 2021 | -1.63% |
| Q1 2021 | -16.39% |
| Q4 2020 | -21.15% |
| Q3 2020 | 6.82% |
| Q2 2020 | -36.76% |
| Q1 2020 | 0.00% |
| Q4 2019 | -81.05% |
| Q3 2019 | 22.78% |
| Q2 2019 | 12.82% |
| Q1 2019 | -158.68% |
| Q4 2018 | 0.19% |
| Q3 2018 | 240.36% |
| Q2 2018 | -1.43% |
| Q1 2018 | 46.90% |
| Q4 2017 | -9.65% |
| Q3 2017 | 4.05% |
| Q2 2017 | -5.77% |
| Q1 2017 | 12.99% |
| Q4 2016 | 14.23% |
| Q3 2016 | -2.60% |
| Q2 2016 | -6.00% |
| Q1 2016 | 42.49% |